Propensity score matching was applied to compare tirzepatide (N=42,600) with non-GLP-1 anti-obesity medications (N=183,460)
Full catalog CJC-1295 Side Effects: Phase 2 Trial Data adverse event profile from clinical trials and community reports References Teichman SL, et al
10.1016/j.taap.2015.01.012 54 GangulyS.DewanjeeS.SenR.ChattopadhyayD.GangulyS.GaonkarR.et al (2021)
Liu W, Zhou W, Zhao P, Wu T, Gu H, Li Y, Zhong C, Bai H, Zhao N, Huang X (2025) PD-Like pathogenesis in Caenorhabditis elegans intestinally infected with Nocardia farcinica and the underlying molecular mechanisms
There are practical reasons too: B can be unstable if mixed with certain other vitamins in solution, and dosing schedules for B deficiency (pernicious anemia, for instance) may differ
Liposomal delivery is designed to bypass digestive breakdown, ensuring the "master antioxidant" is delivered where it is needed most